- Alternative therapy cardiology critical care Dermatology Endocrinology & Metabolism gastroenterology GI & liver harm HEENT Hematology hepatology HIV Hospital medicine ID immunology infection Nephrology Neurology Oncology ophthalmology Orthopaedics patient satisfaction pulmonary medicine renal Reproductive health Rheumatology Surgery Syncope Toxicology Urology vascular
Category Archives: Applying evidence
EUH Resident Report: What are the guidelines for prophylaxis for dental procedures in patients with congenital heart disease?
The Bottom Line: Infective endocarditis (IE) prophylaxis for dental procedures should be recommended only for patients with underlying cardiac conditions associated with the highest risk of adverse outcome from IE. For patients with these underlying cardiac conditions, prophylaxis is recommended … Continue reading →
EUH Resident Report: What are indications for anticoagulants for primary prevention of left ventricular thrombosis?
Bottom line: Indications for anticoagulants for primary prevention of left ventricular thrombosis include patients with the following traits: large anterior infarctions (particularly in the anterior location), heart failure, and high embolic risk (including those with echocardiographic evidence of mobile and … Continue reading →
The Bottom Line: The criteria for eligibility for transplantation were the presence of a tumor 5 cm or less in diameter in patients with single hepatocellular carcinomas (HCC) and no more than three tumor nodules, each 3 cm or less … Continue reading →
Evaluation of Guidelines in Syncope Study (EGSYS) syncope score: Calculate by QxMD (app is freely available for Android and Apple devices), EMERG CDRs (app is freely available for Android devices) Osservatorio Epidemiologico sulla Sincope nel Lazio (OESIL) risk score: American … Continue reading →
The Bottom Line: The effect of antihypertensive treatment in patients with acute ischemic stroke is uncertain. This RCT concluded that bloodpressure reduction with antihypertensive medications, compared with the absence of hypertensive medication, did not reduce the likelihood of death and … Continue reading →
Intermittent vs Continuous Proton Pump Inhibitor Therapy for High-Risk Bleeding Ulcers A Systematic Review and Meta-analysis
Sachar, Hamita, KetaVaidya, and LorenLaine. “Intermittent vs continuous proton pump inhibitor therapy for high-risk bleeding ulcers: a systematic review and meta-analysis.” JAMA internal medicine 174.11 (2014):1755-62. Conclusion: “Intermittent PPI therapy is comparable to the current guideline-recommended regimen of intravenous bolus … Continue reading →
Bottom line: Patients who present to the emergency department with near syncope and syncope are likely to have similar prevalence, etiology, prognosis, critical interventions, and adverse outcomes. Patients with near syncope are less likely to be admitted. Sources Grossman, Shamai … Continue reading →